20-Mar-2017 - Envigo is developing new In vitro tests in advance of the Comprehensive In Vitro Proarrhythmia Assay (CiPA) recommendations expected at the end of the year.
16-Mar-2017 - The US Justice Department has announced Charles River Laboratories International Inc. will pay the US government $1.8m to settle claims that it violated the False Claims Act.
15-Mar-2017 - Heptares Therapeutics has entered into a drug discovery and licensing agreement with Daiichi Sankyo – providing further validation of the company’s structure-based drug design approach, says CEO.
14-Mar-2017 - Cytel Inc. has established a dedicated quantitative pharmacology and pharmacometrics team to meet an increasing demand for model-informed drug development from biopharma clients.
13-Mar-2017 - Charles River Laboratories has extended its integrated respiratory program with Chiesi Farmaceutici, through which it identifies and tests candidates for preclinical development.
13-Mar-2017 - SRI International will advance compounds with the potential to treat persons exposed to biological, radiation, nuclear, and chemical agents – in a deal worth up to $90m.
09-Mar-2017 - Certara has developed a new licensing approach, which provides smaller organizations access to its physiologically-based pharmacokinetic (PBPK) modeling and simulation platform.
09-Mar-2017 - NovAliX has signed an insourcing agreement with UCB Biopharma, a model that the CRO says “energizes scientific organization” and offers "significant" cost advantages.
07-Mar-2017 - Cerveau has signed a research agreement through which it will supply its early-stage imaging agent to assess the stages of Alzheimer’s disease and other neurodegenerative diseases.
06-Mar-2017 - Irish Luxcel will grant access to its consumable in vitro cell toxicity tests to Shanghai-based CRO HD Biosciences to help reduce the risk of post-market drug withdrawal.
02-Mar-2017 - Genesis Biotechnology Group (GBG) has acquired the preclinical CRO PharmOptima in order to provide customers with a single point-of-contact throughout their drug development programs.
01-Mar-2017 - Metrion has partnered with Assay.Works for an exchange of ion channels and high-throughput screening (HTS) services for drug discovery.
27-Feb-2017 - The Global Biological Standards Institute (GBSI) has outlined an action plan after finding the frequency of irreproducible preclinical research exceeds 50% – costing the US nearly $28bn.
23-Feb-2017 - Envigo has developed and validated an analytical method to evaluate the potential effects of thyroid hormone levels in rat F1 offspring.
22-Feb-2017 - Dubbed LAB282, the £13m (€15M) Oxford University drug discovery program with Evotec has announced two grant winners and a second set of awards of up to £250,000.
15-Feb-2017 - Almac Discovery and the Royal College of Surgeons in Ireland (RCSI) and have announced a research collaboration aimed at understanding how to target therapy-resistant cancer tumors.
13-Feb-2017 - Researchers need to design more translationally relevant animal studies to improve the potential for success in human clinical trials, according a recent report.
09-Feb-2017 - Taconic Biosciences has launched a new program to improve access to its cryopreserved mouse models.
08-Feb-2017 - AMRI has entered an alliance through which the global contract research and manufacturing organization will gain access to "new avenues of drug discovery."
02-Feb-2017 - ChemDiv is providing Janssen Research & Development with access to its small molecule discovery platform resources as part of a hit identification collaboration.
01-Feb-2017 - Sekisui XenoTech has added new dermal subcellular fraction test systems to its contract research services.
01-Feb-2017 - Cyprotex is now wholly owned by Evotec and has finished moving its operations into a facility at the BioCity BioHub in Cheshire, UK.
31-Jan-2017 - Outsourcing-Pharma presents this month's round up of who is moving where in the contract research and manufacturing industry.
25-Jan-2017 - Enteris Biopharma has secured two deals in as many days to use its excipient-based platform to enhance delivery of preclinical peptide candidates.
23-Jan-2017 - German CRO Evotec says it will invest in its staff and infrastructure to help service a drug discovery deal with Japan’s Asahi Kasei Pharma.